REVISION THERAPEUTICS
ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. Its product includes Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in 2010 and is based in San Diego, California.
REVISION THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2010-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.revisiontherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
858-768-7860
Total Funding:
3.37 M USD
Technology used in webpage:
Amazon GoDaddy DNS YouTube AWS Global Accelerator
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Current Advisors List
Official Site Inspections
http://www.revisiontherapeutics.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
Loading ... 